WP
IBRX icon

Woodline Partners’s ImmunityBio IBRX Stock Holding History

Woodline Partners’s Portfolio IBRX Stock Details IBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$26.4M Buy
3,447,346
+806
+0% +$5.52K 0.1% 277
2025
Q4 		$6.82M Sell
3,446,540
-1,851,185
-35% -$4.19M 0.03% 555
2025
Q3 		$13M Buy
5,297,725
+1,851,854
+54% +$4.77M 0.06% 377
2025
Q2 		$9.1M Buy
3,445,871
+774
+0% +$2.08K 0.05% 449
2025
Q1 		$10.4M Buy
3,445,097
+2,657
+0.1% +$8.05K 0.07% 354
2024
Q4 		$8.81M Buy
3,442,440
+3,002,622
+683% +$12.5M 0.06% 376
2024
Q3 		$1.64M Buy
439,818
+1,975
+0.5% +$9.14K 0.01% 486
2024
Q2 		$2.77M Buy
+437,843
New +$2.89M 0.03% 391

Other funds holding IBRX

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
HF
HRT Financial New York $26B AUM 58.22% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return